| DC Field | Value | Language |
|---|
| dc.contributor.author | Yusuphodjayeva Hurshida Sobirovna., Islamova Zulfiyahon Saidg‘anihojanovna., Miraziz Muhammadiev Maksudovich | - |
| dc.date.accessioned | 2025-12-23T16:17:17Z | - |
| dc.date.available | 2025-12-23T16:17:17Z | - |
| dc.date.issued | 2025-01 | - |
| dc.identifier.issn | 2776-1010 | - |
| dc.identifier.uri | http://repo.tma.uz/xmlui/handle/1/2792 | - |
| dc.description.abstract | This article explores chemotherapy and immunotherapy, two pivotal approaches in medical
chemistry for treating cancer and other diseases. Chemotherapy involves using chemical agents to
target and destroy rapidly dividing cancer cells, often affecting normal cells. Immunotherapy, on the
other hand, harnesses the patient’s immune system to identify and combat cancer cells with precision.
The mechanisms, advantages, limitations, and combined applications of these therapies are discussed.
Advances in drug design, such as targeted therapy and immune checkpoint inhibitors, have improved
efficacy and reduced side effects, revolutionizing modern treatment paradigms. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | Academiсia Globe: Inderscience Research | en_US |
| dc.subject | chemotherapy, immunotherapy, cancer treatment, medical chemistry, targeted therapy, immune checkpoint inhibitors, cancer cells, drug design, side effects, immune system, modern medicine. | en_US |
| dc.title | CHEMOTHERAPY AND IMMUNOTHERAPY ANNOTATION | en_US |
| dc.type | Article | en_US |
| Appears in Collections: |
|
